Repligen | Stammkapital



Ordinary Share Capital Veränderung Datum
Agilent USD 3M 0 2025-01
Align Technology USD 7K 0 2024-12
Bio Techne USD 1.58M 10K 2024-12
BioMarin Pharmaceutical USD 192K 1000 2025-03
Bristol-Myers Squibb USD 292M 0 2025-03
Bruker USD 1.8M 0 2024-12
Charles River Laboratories USD 511K 6K 2024-12
Danaher USD 9M 0 2025-03
Dentsply International USD 3M 0 2024-12
Exact Sciences USD 1.89M 30K 2025-03
General Electric USD 15M 0 2025-03
Henry Schein USD 1000K 0 2024-12
Illumina USD 2M 0 2024-12
IQVIA Holdings USD 3M 0 2024-12
Mettler Toledo International USD 448K 0 2025-03
Myriad Genetics USD 900K 0 2024-12
Pfizer USD 481M 1000K 2025-03
Repligen USD 562K 1000 2025-03
Revvity USD 120.65M 1.44M 2024-12
Standard Biotools USD 396K 6K 2024-12
Thermo Fisher Scientific USD 444M 0 2024-12
Waters USD 1.63M 1000 2024-12
West Pharmaceutical Services USD 18.8M 0 2024-12



Repligen Stammkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.